Stocks and Investing
Stocks and Investing
Fri, February 3, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Paul Knight Maintained (TECH) at Buy with Decreased Target to $115 on, Feb 3rd, 2023
Paul Knight of Keybanc, Maintained "Bio-Techne Corporation" (TECH) at Buy with Decreased Target from $125 to $115 on, Feb 3rd, 2023.
Paul has made no other calls on TECH in the last 4 months.
There are 5 other peers that have a rating on TECH. Out of the 5 peers that are also analyzing TECH, 2 agree with Paul's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Timothy Daley of "Wells Fargo" Upgraded from Sell to Hold and Held Target at $90 on, Tuesday, January 10th, 2023
- Conor McNamara of "RBC Capital" Initiated at Hold and Held Target at $89 on, Wednesday, December 7th, 2022
These are the ratings of the 3 analyists that currently disagree with Paul
- Justin Bowers of "Deutsche Bank" Initiated at Strong Buy and Held Target at $100 on, Wednesday, December 14th, 2022
- Patrick Donnelly of "Citigroup" Upgraded from Hold to Strong Buy and Increased Target to $100 on, Monday, December 12th, 2022
- Jacob Johnson of "Stephens & Co." Maintained at Buy with Decreased Target to $105 on, Monday, December 5th, 2022
Contributing Sources